Antiviral drugs with extra-cellular sites of action.
Griffiths
P D
PD
D000081:Acetamides / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016860:CD4 Immunoadhesins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D000077560:Enfuvirtide; D006146:Guanidines; D015700:HIV Envelope Protein gp41 / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007555:Isoxazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D053139:Oseltamivir; D010446:Peptide Fragments / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D010649:Phenylalanine / Q000031:analogs & derivatives; D011714:Pyrans; D011760:Pyrrolidinones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D012794:Sialic Acids / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D014633:Valine / Q000031:analogs & derivatives; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D016860:CD4 Immunoadhesins; C096753:CD4-IgG(2); D006146:Guanidines; D015700:HIV Envelope Protein gp41; D007555:Isoxazoles; D010446:Peptide Fragments; D011714:Pyrans; D011760:Pyrrolidinones; D012794:Sialic Acids; D000077560:Enfuvirtide; D053139:Oseltamivir; D010649:Phenylalanine; D014633:Valine; D053243:Zanamivir; C118874:rupintrivir